|
1
|
Kohler BA, Ward E, McCarthy BJ, Schymura
MJ, Ries LA, Eheman C, Jemal A, Anderson RN, Ajani UA and Edwards
BK: Annual report to the nation on the status of cancer, 1975–2007,
featuring tumors of the brain and other nervous system. J Natl
Cancer Inst. 103:714–736. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Popova SN, Bergqvist M, Dimberg A, Edqvist
PH, Ekman S, Hesselager G, Ponten F, Smits A, Sooman L and
Alafuzoff I: Subtyping of gliomas of various WHO grades by the
application of immunohistochemistry. Histopathology. 64:365–379.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ho VK, Reijneveld JC, Enting RH, Bienfait
HP, Robe P, Baumert BG and Visser O: Dutch Society for
Neuro-Oncology (LWNO): Changing incidence and improved survival of
gliomas. Eur J Cancer. 50:2309–2318. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hanahan D and Robert W: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Stine ZE, Walton ZE, Altman BJ, Hsieh AL
and Dang CV: MYC: metabolism, and cancer. Cancer Discov.
5:1024–1039. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Principe DR, Doll JA, Bauer J, Jung B,
Munshi HG, Bartholin L, Pasche B, Lee C and Grippo PJ: TG F-β
Duality of function between tumor prevention and carcinogenesis. J
Natil Cancer Inst. 106:djt3692014. View Article : Google Scholar
|
|
7
|
Wysocka J, Swigut T, Xiao H, Milne TA,
Kwon SY, Landry J, Kauer M, Tackett AJ, Chait BT, Badenhorst P, et
al: A PHD finger of NURF couples histone H3 lysine 4 trimethylation
with chromatin remodelling. Nature. 442:86–90. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jones MH, Hamana N and Shimane M:
Identification and characterization of BPTF, a novel bromodomain
transcription factor. Genomics. 63:35–39. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Goller T, Vauti F, Ramasamy S and Arnold
HH: Transcriptional regulator BPTF/FAC1 is essential for
trophoblast differentiation during early mouse development. Mol
Cell Biol. 28:6819–6827. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ma Y, Liu X, Liu Z, Wei S, Shang H, Xue Y,
Cao Y, Meng A and Wang Q: The chromatin remodeling protein Bptf
promotes posterior neuroectodermal fate by enhancing
Smad2-activated wnt8a expression. J Neurosci. 35:8493–8506. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Richart L, Real FX and Sanchez-Arevalo
Lobo VJ: c-MYC partners with BPTF in human cancer. Mol Cell Oncol.
3:e11523462016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xiao S, Liu L, Lu X, Long J, Zhou X and
Fang M: The prognostic significance of bromodomain PHD-finger
transcription factor in colorectal carcinoma and association with
vimentin and E-cadherin. J Cancer Res Clin Oncol. 141:1465–1474.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dai M, Lu JJ, Guo W, Yu W, Wang Q, Tang R,
Tang Z, Xiao Y, Li Z, Sun W, et al: BPTF promotes tumor growth and
predicts poor prognosis in lung adenocarcinomas. Oncotarget.
6:33878–33892. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2-ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mayes K, Elsayed Z, Alhazmi A, Waters M,
Alkhatib SG, Roberts M, Song C, Peterson K, Chan V, Ailaney N, et
al: BPTF inhibits NK cell activity and the abundance of natural
cytotoxicity receptor co-ligands. Oncotarget. 8:64344–64357. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Boruah D, Deb P, Srinivas V and Mani NS:
Morphometric study of nuclei and microvessels in gliomas and its
correlation with grades. Microvasc Res. 93:52–61. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Louis DN, Perry A, Reifenberger G, von
Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD,
Kleihues P and Ellison DW: The 2016 world health organization
classification of tumors of the central nervous system: A summary.
Acta Neuropathol. 131:803–820. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Minniti G, Muni R, Lanzetta G, Marchetti P
and Enrici RM: Chemotherapy for glioblastoma: Current treatment and
future perspectives for cytotoxic and targeted agents. Anticancer
Res. 29:5171–5184. 2009.PubMed/NCBI
|
|
19
|
Xiao S, Liu L, Fang M, Zhou X, Peng X,
Long J and Lu X: BPTF associated with EMT indicates negative
prognosis in patients with hepatocellular carcinoma. Dig Dis Sci.
60:910–918. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dar AA, Majid S, Bezrookove V, Phan B,
Ursu S, Nosrati M, De Semir D, Sagebiel RW, Miller JR III, Debs R,
et al: BPTF transduces MITF-driven prosurvival signals in melanoma
cells. Proc Natl Acad Sci USA. 113:6254–6258. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Landry J, Sharov AA, Piao Y, Sharova LV,
Xiao H, Southon E, Matta J, Tessarollo L, Zhang YE, Ko MS, et al:
Essential role of chromatin remodeling protein Bptf in early mouse
embryos and embryonic stem cells. PLoS Genet. 4:e10002412008.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xu B, Cai L, Butler JM, Chen D, Lu X,
Allison DF, Lu R, Rafii S, Parker JS, Zheng D and Wang GG: The
chromatin remodeler BPTF activates a stemness gene-expression
program essential for the maintenance of adult hematopoietic stem
cells. Stem Cell Reports. 10:pp. 675–683. 2018, View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Frey WD, Chaudhry A, Slepicka PF,
Ouellette AM, Kirberger SE, Pomerantz WCK, Hannon GJ and Dos Santos
CO: BPTF maintains chromatin accessibility and the self-renewal
capacity of mammary gland stem cells. Stem Cell Reports. 9:pp.
23–31. 2017, View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Buganim Y, Goldstein I, Lipson D,
Milyavsky M, Polak-Charcon S, Mardoukh C, Solomon H, Kalo E, Madar
S, Brosh R, et al: A novel translocation breakpoint within the BPTF
gene is associated with a pre-malignant phenotype. PLoS One.
5:e96572010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dar AA, Nosrati M, Bezrookove V, de Semir
D, Majid S, Thummala S, Sun V, Tong S, Leong SP, Minor D, et al:
The role of BPTF in melanoma progression and in response to
BRAF-targeted therapy. J Natl Cancer Inst. 107:djv0342015.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Richart L, Carrillo-de Santa Pau E,
Río-Machín A, de Andrés MP, Cigudosa JC, Lobo VJ and Real FX: BPTF
is required for c-MYC transcriptional activity and in vivo
tumorigenesis. Nat Commun. 7:101532016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li Y, Li J, Luo M, Zhou C, Shi X, Yang W,
Lu Z, Chen Z, Sun N and He J: Novel long noncoding RNA NMR promotes
tumor progression via NSUN2 and BPTF in esophageal squamous cell
carcinoma. Cancer Lett. 430:57–66. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jordan-Sciutto KL, Dragich JM, Caltagarone
J, Hall DJ and Bowser R: Fetal Alz-50 clone 1 (FAC1) protein
interacts with the Myc-associated zinc finger protein (ZF87/MAZ)
and alters its transcriptional activity. Biochemistry.
39:3206–3215. 2000. View Article : Google Scholar : PubMed/NCBI
|
